ANZ News
After setting up a 24/7 digital GP front door, the New Zealand government has provided funding for a new online platform to access mental health services.
Developed by Cancer Institute NSW, the multi-data-trained tool aims to educate people over 40 about their cancer risks.
Also, Topcon acquires New Zealand-founded Toku to expand access to AI-based health screening using retinal images.
Back2U connects patients to nearby certified practitioners in minutes using a custom geolocation engine.
PredicTx expands clinical trial from Australia to India and the Middle East while working towards TGA approval and CE marking.
Care GP CEO Melvin Chen discusses how the company is rolling out its platform nationwide.
Also, a startup from Melbourne has raised $1 million in pre-seed funding for its chemotherapy dosing AI.
Also, a new AI-driven genomics platform developed in Queensland can identify cancer biomarkers and predict tumour responses to chemotherapy.
About 300 million prescription records were used to train the AI to reveal drug safety issues and opportunities for repurposing medicines.
Developed with Murdoch Children's Research Institute, the AI has shown 90% detection accuracy.